Screening for pulmonary and cerebral arteriovenous malformations in children with hereditary haemorrhagic telangiectasia

European Respiratory Journal

Volumn 34, Issue 4, 2009, Pages 875-881

  Al Saleh, S ^a,b,c   Mei Zahav, M ^a,b   Faughnan, M E ^a,d,e   MacLusky, I B ^a,b   Carpenter, S ^a,b   Letarte, M ^a,b   Ratjen, F ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Arteriovenous malformations; Diagnosis; Hereditary haemorrhagic telangiectasia; Rendu Osler Weber; Screening

Indexed keywords

ARTICLE; BRAIN ARTERIOVENOUS MALFORMATION; CHILD; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ARTERIOVENOUS FISTULA; RENDU OSLER WEBER DISEASE; SCREENING TEST;

ACTIVIN RECEPTORS, TYPE II; ADOLESCENT; ANTIGENS, CD; ARTERIOVENOUS MALFORMATIONS; BRAIN; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; LUNG; MAGNETIC RESONANCE IMAGING; MALE; MASS SCREENING; PHENOTYPE; PREVALENCE; PROSPECTIVE STUDIES; RECEPTORS, CELL SURFACE; RISK FACTORS; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70349651508     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00030009     Document Type: Article

References (56)

1. Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med 1999; 245: 31-39. (Pubitemid 29049140)
2. Dakeishi M, Shioya T, Wada Y, et al. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 2002; 19: 140-148. (Pubitemid 34121805)
3. Guttmacher AE, McKinnon WC, Upton MD. Hereditary hemorrhagic telangiectasia: a disorder in search of the genetics community. Am J Med Genet 1994; 52: 252-253.
4. Bideau A, Plauchu H, Brunet G, et al. Epidemiological investigation of Rendu-Osler disease in France: its geographical distribution and prevalence. Popul 1989; 44: 3-22.
5. Lesca G, Olivieri C, Burnichon N, et al. Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network. Genet Med 2007; 9: 14-22. (Pubitemid 46105845)
6. Bayrak-Toydemir P, McDonald J, Markewitz B, et al. Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations. Am JMed Genet A 2006; 140: 463-470. (Pubitemid 43376318)
7. Letteboer TG, Mager JJ, Snijder RJ, et al. Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet 2006; 43: 371-377.
8. Giordano P, Nigro A, Lenato GM, et al. Screening for children from families with Rendu-Osler-Weber disease: from geneticist to clinician. J Thromb Haemost 2006; 4: 1237-1245. (Pubitemid 43756700)
9. Prigoda NL, Savas S, Abdalla SA, et al. Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations. J Med Genet 2006; 43: 722-728. (Pubitemid 44483914)
10. Abdalla SA, Letarte M. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet 2006; 43: 97-110. (Pubitemid 43262964)
11. Gallione CJ, Richards JA, Letteboer TG, et al. SMAD4 mutations found in unselected HHT patients. J Med Genet 2006; 43: 793-797.
12. Cole SG, Begbie ME, Wallace GM, et al. A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet 2005; 42: 577-582. (Pubitemid 40993833)
13. Bayrak-Toydemir P, McDonald J, Akarsu N, et al. A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet A 2006; 140: 2155-2162. (Pubitemid 44522429)
14. Letteboer TG, Zewald RA, Kamping EJ, et al. Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Dutch patients. Hum Genet 2005; 116: 8-16. (Pubitemid 40057910)
15. Schulte C, Geisthoff U, Lux A, et al. High frequency of ENG and ALK1/ACVRL1 mutations in German HHT patients. Hum Mutat 2005; 25: 595.
16. Fernández-L A, Sanz-Rodriguez F, Blanco FJ, et al. Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-β signaling pathway. Clin Med Res 2006; 4: 66-78.
17. Toporsian M, Gros R, Kabir MG, et al. A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res 2005; 96: 684-692. (Pubitemid 40478336)
18. Haitjema T, Balder W, Disch FJ, et al. Epistaxis in hereditary haemorrhagic telangiectasia. Rhinology 1996; 34: 176-178.
19. Aassar OS, Friedman CM, White RI Jr. The natural history of epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 1991; 101: 977-980.
20. Shah RK, Dhingra JK, Shapshay SM. Hereditary hemorrhagic telangiectasia: a review of 76 cases. Laryngoscope 2002; 112: 767-773. (Pubitemid 34477602)
21. Plauchu H, de Chadarévian JP, Bideau A, et al. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 1989; 32: 291-297. (Pubitemid 19146524)
22. Nanthakumar K, Graham AT, Robinson TI, et al. Contrast echocardiography for detection of pulmonary arteriovenous malformations. Am Heart J 2001; 141: 243-246. (Pubitemid 32128729)
23. Maher CO, Piepgras DG, Brown RD Jr, et al. Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke 2001; 32: 877-882.
24. Ference BA, Shannon TM, White RI Jr, et al. Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia. Chest 1994; 106: 1387-1390. (Pubitemid 24346096)
25. Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995; 333: 918-924.
26. Cottin V, Chinet T, Lavolé A, et al. Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126 patients. Medicine (Baltimore) 2007; 86: 1-17. (Pubitemid 46104915)
27. Gallitelli M, Guastamacchia E, Resta F, et al. Pulmonary arteriovenous malformations, hereditary hemorrhagic telangiectasia, and brain abscess. Respiration 2006; 73: 553-557. (Pubitemid 43909762)
28. Pollak JS, Saluja S, Thabet A, et al. Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations. J Vasc Interv Radiol 2006; 17: 35-44. (Pubitemid 44392031)
29. Moussouttas M, Fayad P, Rosenblatt M, et al. Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations. Neurology 2000; 55: 959-964. (Pubitemid 30764357)
30. Lacombe P, Lagrange C, Beauchet A, et al. Diffuse pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: long-term results of embolization according to the extent of lung involvement. Chest 2008; 135: 1031-1037.
31. Gallitelli M, Pasculli G, Fiore T, et al. Emergencies in hereditary haemorrhagic telangiectasia. QJM 2006; 99: 15-22.
32. Shovlin CL, Jackson JE, Bamford KB, et al. Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax 2008; 63: 259-266.
33. Gazzaniga P, Buscarini E, Leandro G, et al. Contrast echocardiography for pulmonary arteriovenous malformations screening: does any bubble matter? Eur J Echocardiogr 2009; 10: 513-518.
34. van Gent MW, Post MC, Luermans JG, et al. Screening for pulmonary arteriovenous malformations using transthoracic contrast echocardiography: a prospective study. Eur Respir J 2009; 33: 85-91.
35. van Gent MW, Post MC, Snijder RJ, et al. Grading of pulmonary right-to-left shunt with transthoracic contrast echocardiography: does it predict the indication for embolotherapy? Chest 2009; 135: 1288-1292.
36. Folz BJ, Wollstein AC, Alfke H, et al. The value of screening for multiple arterio-venous malformations in hereditary hemorrhagic telangiectasia: a diagnostic study. Eur Arch Otorhinolaryngol 2004; 261: 509-516. (Pubitemid 39506431)
37. Kjeldsen AD, Oxhøj H, Andersen PE, et al. Pulmonary arteriovenous malformations: screening procedures and pulmonary angiography in patients with hereditary hemorrhagic telangiectasia. Chest 1999; 116: 432-439. (Pubitemid 29382129)
38. Cottin V, Plauchu H, Bayle JY, et al. Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. Am J Respir Crit Care Med 2004; 169: 994-1000. (Pubitemid 38543636)
39. Abdalla SA, Geisthoff UW, Bonneau D, et al. Visceral manifestations in hereditary haemorrhagic telangiectasia type 2. J Med Genet 2003; 40: 494-502. (Pubitemid 36843071)
40. Curie A, Lesca G, Cottin V, et al. Long-term follow-up in 12 children with pulmonary arteriovenous malformations: confirmation of hereditary hemorrhagic telangiectasia in all cases. J Pediatr 2007; 151: 299-306. (Pubitemid 47299098)
41. Mei-Zahav M, Letarte M, Faughnan ME, et al. Symptomatic children with hereditary hemorrhagic telangiectasia: a pediatric center experience. Arch Pediatr Adolesc Med 2006; 160: 596-601. (Pubitemid 43854400)
42. Folz BJ, Zoll B, Alfke H, et al. Manifestations of hereditary hemorrhagic telangiectasia in children and adolescents. Eur Arch Otorhinolaryngol 2006; 263: 53-61. (Pubitemid 43004712)
43. Morgan T, McDonald J, Anderson C, et al. Intracranial hemorrhage in infants and children with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome). Pediatrics 2002; 109: E12.
44. Faughnan ME, Thabet A, Mei-Zahav M, et al. Pulmonary arteriovenous malformations in children: outcomes of transcatheter embolotherapy. J Pediatr 2004; 145: 826-831. (Pubitemid 39586623)
45. Roy C, Noseda G, Arzimanoglou A, et al. Rendu Osler disease revealed by ruptured cerebral arterial aneurysm in an infant. Arch Fr Pediatr 1990; 47: 741-742.
46. Matsubara S, Mandzia JL, ter Brugge K, et al. Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia. AJNR Am J Neuroradiol 2000; 21: 1016-1020. (Pubitemid 30390534)
47. Willemse RB, Mager JJ, Westermann CJ, et al. Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg 2000; 92: 779-784. (Pubitemid 30243925)
48. García-Mónaco R, Taylor W, Rodesch G, et al. Pial arteriovenous fistula in children as presenting manifestation of Rendu-Osler-Weber disease. Neuroradiology 1995; 37: 60-64.
49. John PR. Early childhood presentation of neurovascular disease in hereditary haemorrhagic telangiectasia. Pediatr Radiol 1992; 22: 140-141.
50. Byard RW, Schliebs J, Koszyca BA. Osler-Weber-Rendu syndrome - pathological manifestations and autopsy considerations. J Forensic Sci 2001; 46: 698-701. (Pubitemid 32520598)
51. Reyes-Mú jica M, López-Corella E, Pérez- Fernández L, et al. Osler-Weber-Rendu disease in an infant. Hum Pathol 1988; 19: 1243-1246.
52. Haitjema TJ, Overtoom TT, Westermann CJ, et al. Embolisation of pulmonary arteriovenous malformations: results and follow up in 32 patients. Thorax 1995; 50: 719-723.
53. White RI Jr, Pollak JS, Wirth JA. Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol 1996; 7: 787-804. (Pubitemid 126729603)
54. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000; 91: 66-67. (Pubitemid 30127562)
55. Shovlin CL, Tighe HC, Davies RJ, et al. Embolisation of pulmonary arteriovenous malformations: no consistent effect on pulmonary artery pressure. Eur Respir J 2008; 32: 162-169.
56. Buscarini E, Danesino C, Olivieri C, et al. Doppler ultrasonographic grading of hepatic vascular malformations in hereditary hemorrhagic telangiectasia - results of extensive screening. Ultraschall Med 2004; 25: 348-355. (Pubitemid 39304438)